The Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) Is a Valid and Low-Cost Tool for Evaluation of Dysphagia: A Gold-Standard Comparison Study
Journal of Aging Research · 13.03.2019 · 2019 · 1-7
DOI: 10.1155/2019/7984635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Aging Research, erschienen am 13.03.2019. Verfasst von Larissa L Branco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biomedical Gerontology, School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Themen: Dysphagie
Abstract (Originalsprache)
Background
Dysphagia is a predictor of mortality in Parkinson’s disease (PD). Developing alternative methods to videofluoroscopy swallowing study (VFSS) for the evaluation of dysphagia is a public health necessity. The Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) is an alternative and low-cost tool for diagnosis of dysphagia, but had not been properly validated in comparison to the gold-standard method. The objective of this study was to assess the validity and reliability of the SCAS-PD.
Methods
SCAS-PD was applied to 31 patients with PD, and VFSS was conducted concurrently. This clinical assessment uses different volumes and viscosities to identify signs of swallowing impairments. For validation purposes, the interclass correlation coefficient and the weighted kappa were calculated. The AUC of the ROC curve, sensitivity, and specificity values for detection of penetration/aspiration (PA) were assessed. Internal consistency was calculated by Cronbach’s alpha.
Results
Fifty-one percent of patients were classified with dysphagia. SCAS-PD was differentiated between normal/functional deglutition and dysphagia with AUC 0.97, 95% CI 0.92–1.00, and an optimal cutoff at 19 (sensitivity 100% and specificity 87.5%). The internal consistency was α = 0.91 for the total score. The internal consistency of the SCAS-PD domains was oral phase ( α = 0.73), pharyngeal phase ( α = 0.86), and signs of PA ( α = 0.95). The weighted kappa analysis demonstrated a high rate of concordance at 0.71 ( p < 0.001 ) between SCAS-PD and VFSS.
Conclusions
SCAS-PD has been shown to have a good concordance with the VFSS. Considering this, SCAS-PD is highly applicable in clinical settings, since it is a simple and low-cost diagnostic tool for detecting dysphagia in PD patients.
Autor:innen und Institutionen
- Graduate Program in Biomedical Gerontology, School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
- Department of Neurology, São Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
ORCID-Profile: Carla Helena Augustin Schwanke, Fernanda Loureiro
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Branco, L. L., Trentin, S., Augustin Schwanke, C. H., Gomes, I., & Loureiro, F. (2019). The Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) Is a Valid and Low-Cost Tool for Evaluation of Dysphagia: A Gold-Standard Comparison Study. Journal of Aging Research, 2019, 1-7. https://doi.org/10.1155/2019/7984635
Vancouver
Branco LL, Trentin S, Augustin Schwanke CH, Gomes I, Loureiro F. The Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) Is a Valid and Low-Cost Tool for Evaluation of Dysphagia: A Gold-Standard Comparison Study. Journal of Aging Research. 2019;2019:1-7. doi:10.1155/2019/7984635
BibTeX
@article{Branco2019,
author = {Branco, Larissa L and Trentin, Sheila and Augustin Schwanke, Carla Helena and Gomes, Irenio and Loureiro, Fernanda},
title = {The Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) Is a Valid and Low-Cost Tool for Evaluation of Dysphagia: A Gold-Standard Comparison Study},
journal = {Journal of Aging Research},
year = {2019},
volume = {2019},
pages = {1--7},
doi = {10.1155/2019/7984635}
}
EUVIMED